You are here

AusPAR: Regdanvimab

Australian Public Assessment Report

7 December 2021
AusPAR Details
AusPAR
Active Ingredient
Regdanvimab
Product Name
Regkirona
Sponsor
Celltrion Healthcare Australia Pty Ltd
Submission Number
PM-2021-04004-1-2
Submission Type
New biological entity
Decision
Approved for provisional registration
AusPAR Date
6 December 2021
Publication Date

7 December 2021